22.626 articles found

METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS.

SHI YI, NAGELE ROBERT.

· 2009-11-10

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Tansey MG, Goldberg MS.

Neurobiol Dis · 2009-11-10

DOI: 10.1016/j.nbd.2009.11.004PMID: 19913097

NOVEL PEPTIDES UPREGULATING BDNF EXPRESSION AND PHARMACEUTICAL COMPOSITION FOR PROTECTION AND THERAPY AGAINST ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE COMPRISING THE SAME

KIM KIL LYONG, KIM HONG GI, JUNG WOO RAM, PARK DONG IK, SHIN MIN KYOO.

· 2009-11-06

GOLD NANOPARTICLES COATED WITH POLYELECTROLYTES AND USE THEREOF AS MEDICAMENT FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CAUSED BY PROTEIN AGGREGATES

LEGNAME GIUSEPPE ANTONIO, KROL SILKE, COSTA DE SOUSA MARIA FERNANDA.

· 2009-11-05

Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference.

Müller T.

Patient Prefer Adherence · 2009-11-03

DOI: 10.2147/ppa.s4084PMID: 19936145

Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias.

López-Ariztegui N, Arévalo MA, de Ceballos ML, Grandas F.

Clin Neuropharmacol · 2009-11-01

DOI: 10.1097/wnf.0b013e3181b40378PMID: 19667975

RNAi for the treatment of prion disease: a window for intervention in neurodegeneration?

White MD, Mallucci GR.

CNS Neurol Disord Drug Targets · 2009-11-01

DOI: 10.2174/187152709789541934PMID: 19702576

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

Manca D, Cossu G, Murgia D, Molari A, Ferrigno P, Marcia E, Melis M.

Mov Disord · 2009-11-01

DOI: 10.1002/mds.22807PMID: 19795477

Levodopa-induced dyskinesias in Parkinson disease are independent of the extent of striatal dopaminergic denervation: a pharmacological and SPECT study.

Linazasoro G, Van Blercom N, Bergaretxe A, Iñaki FM, Laborda E, Ruiz Ortega JA.

Clin Neuropharmacol · 2009-11-01

DOI: 10.1097/wnf.0b013e3181b52792PMID: 19855268

[Cell and ex vivo gene therapy: advances in the treatment of central nervous system disorders].

Mejía-Toiber J, Castillo CG, Giordano M.

Rev Neurol · 2009-11-01

DOI: 10.33588/rn.4909.2009176PMID: 19859890

The effect of memantine and levodopa/carbidopa on the responses of phrenic nerve-diaphragm preparations from aged rats.

El-Moursy SA, Shawky HM, Abdel Wahab Z, Rashed L.

Med Sci Monit · 2009-11-01

PMID: 19865051

Gait analysis in patients with Parkinson's disease off dopaminergic therapy.

Svehlík M, Zwick EB, Steinwender G, Linhart WE, Schwingenschuh P, Katschnig P, Ott E, Enzinger C.

Arch Phys Med Rehabil · 2009-11-01

DOI: 10.1016/j.apmr.2009.06.017PMID: 19887212